Ionis Pharmaceuticals

$51.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.89 (+1.77%) Today
$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell IONS and other stocks, options, and ETFs commission-free!

About IONS

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA. The listed name for IONS is Ionis Pharmaceuticals, Inc. Common Stock.

CEO
Brett P. Monia
Employees
817
Headquarters
Carlsbad, California
Founded
1989
Market Cap
7.15B
Price-Earnings Ratio
126.56
Dividend Yield
Average Volume
728.70K
High Today
$51.19
Low Today
$50.01
Open Price
$50.16
Volume
415.88K
52 Week High
$66.22
52 Week Low
$39.32

Collections

IONS Earnings

-$0.35
$0.21
$0.77
$1.33
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 24, Pre-Market

You May Also Like